Back to Search
Start Over
In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model
- Source :
- Radiation Oncology, Vol 7, Iss 1, p 52 (2012), Radiation Oncology (London, England)
- Publication Year :
- 2012
- Publisher :
- BMC, 2012.
-
Abstract
- Purpose Histone deacetylase inhibitors are promising new substances in cancer therapy and have also been shown to sensitize different tumor cells to irradiation (XRT). We explored the effect as well as the radiosensitizing properties of suberoylanilide hydroxamic acid (SAHA) in vivo in a malignant rhabdoid tumor (MRT) mouse model. Methods and material Potential radiosensitization by SAHA was assessed in MRT xenografts by analysis of tumor growth delay, necrosis (HE), apoptosis (TUNEL), proliferation (ki-67) and γH2AX expression as well as dynamic 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG -PET) after treatment with either SAHA alone, single-dose (10 Gy) or fractionated XRT (3 × 3Gy) solely as well as in combination with SAHA compared to controls. Results SAHA only had no significant effect on tumor growth. Combination of SAHA for 8 days with single-dose XRT resulted in a higher number of complete remissions, but failed to prove a significant growth delay compared to XRT only. In contrast fractionated XRT plus SAHA for 3 weeks did induce significant tumor growth delay in MRT-xenografts. The histological examination showed a significant effect of XRT in tumor necrosis, expression of Ki-67, γH2AX and apoptosis. SAHA only had no significant effect in the histological examination. Comparison of xenografts treated with XRT and XRT plus SAHA revealed a significantly increased γH2AX expression and apoptosis induction in the mice tumors after combination treatment with single-dose as well as fractionated XRT. The combination of SAHA with XRT showed a tendency to increased necrosis and decrease of proliferation compared to XRT only, which, however, was not significant. The 18F-FDG-PET results showed no significant differences in the standard uptake value or glucose transport kinetics after either treatment. Conclusion SAHA did not have a significant effect alone, but proved to enhance the effect of XRT in our MRT in vivo model.
- Subjects :
- lcsh:Medical physics. Medical radiology. Nuclear medicine
Radiation-Sensitizing Agents
Necrosis
medicine.drug_class
medicine.medical_treatment
lcsh:R895-920
Malignant rhabdoid tumor
Mice, Nude
Standardized uptake value
Apoptosis
Hydroxamic Acids
Histone deacetylase inhibition
lcsh:RC254-282
Mice
In vivo
In Situ Nick-End Labeling
Medicine
Animals
Humans
Radiology, Nuclear Medicine and imaging
Rhabdoid Tumor
Suberoylanilide hydroxamic acid
Vorinostat
Radiotherapy
business.industry
Research
Histone deacetylase inhibitor
Chemoradiotherapy
Flow Cytometry
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Immunohistochemistry
Xenograft Model Antitumor Assays
Radiation therapy
Histone Deacetylase Inhibitors
Disease Models, Animal
Oncology
Radiology Nuclear Medicine and imaging
Positron-Emission Tomography
Immunology
Cancer research
Tumor necrosis factor alpha
Female
medicine.symptom
business
Subjects
Details
- Language :
- English
- Volume :
- 7
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Radiation Oncology
- Accession number :
- edsair.doi.dedup.....62a9e2ef5bc09ddfadf4f8724134ee85